Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. The Spinal Implants segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Orthofix Extremities segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Phone214-937-2000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$453.04 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date4/29/2019 (Estimated)
OptionableOptionable
Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions
What is Orthofix Medical's stock symbol?
Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."
How were Orthofix Medical's earnings last quarter?
Orthofix Medical Inc (NASDAQ:OFIX) posted its quarterly earnings data on Monday, October, 29th. The medical device company reported $0.43 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.34 by $0.09. The medical device company earned $111.70 million during the quarter, compared to analyst estimates of $110.65 million. Orthofix Medical had a return on equity of 11.36% and a net margin of 3.05%. The business's quarterly revenue was up 6.2% on a year-over-year basis. During the same period last year, the company posted $0.42 EPS. View Orthofix Medical's Earnings History.
When is Orthofix Medical's next earnings date?
What guidance has Orthofix Medical issued on next quarter's earnings?
Orthofix Medical issued an update on its FY19 earnings guidance on Monday, February, 25th. The company provided EPS guidance of $1.75-1.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.86. The company issued revenue guidance of $472-477 million, compared to the consensus revenue estimate of $479.37 million.Orthofix Medical also updated its FY 2019 guidance to $1.75-1.82 EPS.
What price target have analysts set for OFIX?
2 analysts have issued 1 year target prices for Orthofix Medical's shares. Their forecasts range from $60.00 to $60.00. On average, they expect Orthofix Medical's stock price to reach $60.00 in the next year. This suggests a possible upside of 6.1% from the stock's current price. View Analyst Price Targets for Orthofix Medical.
What is the consensus analysts' recommendation for Orthofix Medical?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthofix Medical.
Has Orthofix Medical been receiving favorable news coverage?
Headlines about OFIX stock have trended somewhat negative this week, according to InfoTrie. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Orthofix Medical earned a news impact score of -1.4 on InfoTrie's scale. They also assigned media coverage about the medical device company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the immediate future.
Who are some of Orthofix Medical's key competitors?
Some companies that are related to Orthofix Medical include Tandem Diabetes Care (TNDM), Merit Medical Systems (MMSI), NuVasive (NUVA), Glaukos (GKOS), Cantel Medical (CMD), Irhythm Technologies (IRTC), Nevro (NVRO), Atrion (ATRI), Mazor Robotics (MZOR), Cardiovascular Systems (CSII), K2M Group (KTWO), AtriCure (ATRC), Luminex (LMNX), Tactile Systems Technology (TCMD) and Cryolife (CRY).
What other stocks do shareholders of Orthofix Medical own?
Who are Orthofix Medical's key executives?
Orthofix Medical's management team includes the folowing people:
- Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
- Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
- Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
- Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
- Mr. Davide Bianchi, Pres of Global Orthofix Extremities (Age 54)
Who are Orthofix Medical's major shareholders?
Orthofix Medical's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (15.37%), Dimensional Fund Advisors LP (4.70%), Segall Bryant & Hamill LLC (2.79%), Norges Bank (2.37%), Paradice Investment Management LLC (2.05%) and Northern Trust Corp (1.87%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Raymond Fujikawa, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.
Which major investors are selling Orthofix Medical stock?
OFIX stock was sold by a variety of institutional investors in the last quarter, including Krensavage Asset Management LLC, Krensavage Asset Management LLC, Segall Bryant & Hamill LLC, Mackay Shields LLC, Fort Washington Investment Advisors Inc. OH, SG Americas Securities LLC, KBC Group NV and Citigroup Inc.. Company insiders that have sold Orthofix Medical company stock in the last year include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick and Rice Doug. View Insider Buying and Selling for Orthofix Medical.
Which major investors are buying Orthofix Medical stock?
OFIX stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Victory Capital Management Inc., Tygh Capital Management Inc., BlackRock Inc., Two Sigma Investments LP, Ontario Teachers Pension Plan Board, Martingale Asset Management L P and Bank of Montreal Can. View Insider Buying and Selling for Orthofix Medical.
How do I buy shares of Orthofix Medical?
Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Orthofix Medical's stock price today?
One share of OFIX stock can currently be purchased for approximately $56.54.
How big of a company is Orthofix Medical?
Orthofix Medical has a market capitalization of $1.08 billion and generates $453.04 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.96 on an earnings per share basis.
What is Orthofix Medical's official website?
How can I contact Orthofix Medical?
Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]
MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)
MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
